Position in MRVI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,956,120
+$585,733 QoQ
Shares Held
313,481
-35.3% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. MRVI ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,956,120 | 313,481 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,370,387 | 484,236 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,696,636 | 522,042 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $925,235 | 322,382 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $593,369 | 246,212 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $200,027 | 90,511 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $635,991 | 116,696 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $919,165 | 110,610 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $415,493 | 58,030 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,741,090 | 200,818 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $482,654 | 73,688 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,815,660 | 181,566 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $29,096,886 | 2,340,860 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $33,974,500 | 2,425,018 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $26,425,916 | 1,846,675 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $51,998,326 | 2,036,754 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $42,772,417 | 1,505,541 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $53,794,577 | 1,525,222 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $53,529,552 | 1,277,555 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $43,407,429 | 884,422 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,219,408 | 53,185 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $288,398 | 8,092 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $18,709 | 667 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||